Skip to main content
. 2016 Nov 29;8(1):1628–1640. doi: 10.18632/oncotarget.13703

Figure 4. Meta-analysis of impact of PKM2 expression on disease-free survival/progression-free survival/recurrence-free survival of patients with solid cancers.

Figure 4

Results are presented as individual and pooled HR, and 95% CI.